Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
about
The Role of Interleukin-17 in Lung CancerAutophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells.CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway.Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphomaCCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition.The Th17 pathway and inflammatory diseases of the intestines, lungs, and skinHistone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.Bronchial airway gene expression in smokers with lung or head and neck cancer.The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcomeRetinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resectionOverexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.The effect of proinflammatory cytokines on IL-17RA expression in NSCLC.
P2860
Q28066949-857CCDAF-0E6E-449F-9F9C-271CA7B5F8F6Q33577585-6A3468A7-3831-4707-AAB0-6988D436F099Q33670321-B31878FC-1BFC-40AC-9440-0DB32229DFFDQ33799673-FE162C78-AF51-4B35-938C-B9C86708ECCBQ34506935-8D02949E-5BE1-4890-9771-B670F4D4488EQ34570874-B87F7139-3704-4251-8CA7-1D3FAF739231Q35730080-F157EB2F-8449-4871-9306-F968537A6685Q36084943-BF851CBE-BA25-4DD0-94CA-FA938A9BD59FQ36159383-F922FF6E-C3E5-4DA6-9DBE-651B9FCBD475Q36337082-FD0FE6E8-725E-401E-BA81-C2A626232F70Q36583985-C6A51C14-FD6B-4233-8ED1-7CDB4DF2BD19Q36797488-C1DEF43C-6BAA-4E79-94FB-CD18AC69194BQ36960019-12A9F46C-0A70-4EA9-BEC1-9DEC0B7C8D42Q37046394-35A93EAA-F4B7-43F8-A462-3B7F83252D77Q37174010-9060E35D-8BAF-4C5C-80C6-D0EA77BA947CQ37662888-E4CCA500-BF93-4257-90A5-2574BB01D9C5Q37702571-4FA75D4F-4246-4211-809C-1231C4B7995AQ37703387-FD23AA5D-F8C5-43B2-ACC0-39AD538D5CE7Q38264982-B75FCA38-8F45-49B1-9F4E-5EF4D06D53E8Q38839707-BA81F929-AE2D-45C7-AF17-4EE3623AEC49Q38907909-7F5AF6F0-87BB-4283-B736-8B7F05EA6C61Q39014889-36B836D5-9A16-404A-A1AB-9E527D7BD4B4Q40406187-E7B9DC4F-ED97-4F58-A8AD-70659C82958FQ42720306-FD731347-B490-4CAB-A1BE-905DBA95826AQ44228801-FA5E313B-86FD-4799-B978-94B48F6C1433Q51704734-6FF04739-99B3-4E53-8238-22623B075ED8
P2860
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@ast
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@en
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@nl
type
label
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@ast
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@en
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@nl
prefLabel
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@ast
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@en
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@nl
P2093
P2860
P1433
P1476
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
@en
P2093
Amnon Peled
Fiona Vernea
Gideon Zamir
Hanna Wald
Jonathan Demma
Katia Beider
Oz M Shapira
Sophie Kirshberg
P2860
P304
P356
10.1371/JOURNAL.PONE.0024856
P407
P577
2011-09-15T00:00:00Z